GLP-1 is a 30-amino-acid peptide that cannot easily cross the skin barrier without chemical modification or penetration enhancers
Lancet 398 , 1431556 (2021)
Using a weight-loss medication is in no way the easy way out, he notes
Besides, it seems that behavioral phenotypes in the VPA model emerge from altered developmental trajectories rather than acute oxidative imbalance, which may explain why postnatal redox modulation failed to rescue sociability and exploratory behavior
Darien Sutton, a board-certified emergency medicine physician, noted the study does not show precisely whether the GLP-1 drugs reduce the risk of cancer, or whether the weight loss they cause may lead to the lower risk
This dose is sub-therapeutic by design